Academic Journal
Newly diagnosed non‐small cell lung cancer with interstitial lung abnormality: Prevalence, characteristics, and prognosis
العنوان: | Newly diagnosed non‐small cell lung cancer with interstitial lung abnormality: Prevalence, characteristics, and prognosis |
---|---|
المؤلفون: | Min Zhu, Jiawen Yi, Yanping Su, Yixiao Zhang, Yanli Gao, Xiaoli Xu, Shu Zhang, Yuhui Zhang, Kewu Huang |
المصدر: | Thoracic Cancer, Vol 14, Iss 19, Pp 1874-1882 (2023) |
بيانات النشر: | Wiley, 2023. |
سنة النشر: | 2023 |
المجموعة: | LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
مصطلحات موضوعية: | EGFR, interstitial lung abnormality, non‐small cell lung cancer, usual interstitial pneumonia, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
الوصف: | Abstract Background Along with the improvement of lung cancer screening implementation, the identification of interstitial lung abnormality (ILA) is increasing. Currently, there is a limited description of the oncogenic status and ILA subtypes among newly diagnosed non‐small cell lung cancer (NSCLC) patients with ILA in the Chinese population. This study aimed to investigate the prevalence, characteristics, oncogenic status and factors associated with overall survival (OS) among NSCLC patients with ILA. Methods A total of 765 newly diagnosed NSCLC cases at our hospital were reviewed and ILA was diagnosed according to the criteria of the Fleischner Society. The characteristics, clinical pathological features and OS of NSCLC patients with ILA were retrospectively analyzed. Results Of the 765 patients included in the study, 101 (13.2%) cases experienced ILA at the time of NSCLC diagnosis. Multivariate analysis revealed that ILA was more likely to be detected in NSCLC patients who were age ≥60 (OR 2.404, p = 0.001), male gender (OR 2.476, p = 0.004), and EGFR wild‐type (OR 2.035, p = 0.007). Additionally, according to the multivariate Cox model, the presence of ILA in NSCLC patients was significantly associated with a shorter OS period than those without ILA (751 days vs. 445 days, HR 0.6, p = 0.001). Following analysis, it was determined that OS in patients with usual interstitial pneumonia (UIP) was shorter than in those without UIP (HR 1.82, p = 0.037). Conclusion ILA is a common comorbidity among newly diagnosed NSCLC patients. We found that patients with EGFR wild‐type NSCLC were more likely to develop ILA. The presence of ILA, especially UIP, was significantly associated with poor NSCLC prognosis. |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 1759-7714 1759-7706 |
Relation: | https://doaj.org/toc/1759-7706; https://doaj.org/toc/1759-7714 |
DOI: | 10.1111/1759-7714.14935 |
URL الوصول: | https://doaj.org/article/fb0f0af5f52b4e49bfa9b66fa0e50a26 |
رقم الانضمام: | edsdoj.fb0f0af5f52b4e49bfa9b66fa0e50a26 |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 17597714 17597706 |
---|---|
DOI: | 10.1111/1759-7714.14935 |